Rapidly Self-Sterilizing PPE Capable of Destroying 100% of Microbes in 30-60 Seconds.

Autor:	Zinn AA; Kuprion®, Inc., San Jose, CA, United States., Izadjoo M; Kuprion®, Inc., San Jose, CA, United States.; Integrated Pharma Services, Frederick, MD, United States., Kim H; Integrated Pharma Services, Frederick, MD, United States., Brody RL; Kuprion®, Inc., San Jose, CA, United States., Roth RR; Kuprion®, Inc., San Jose, CA, United States., Vega A; Kuprion®, Inc., San Jose, CA, United States., Nguyen KK; Kuprion®, Inc., San Jose, CA, United States., Ngo NT; Kuprion®, Inc., San Jose, CA, United States., Zinn HT; Kuprion®, Inc., San Jose, CA, United States., Antonopoulos N; Kuprion®, Inc., San Jose, CA, United States., Stoltenberg RM; Kuprion®, Inc., San Jose, CA, United States.
Jazyk:	angličtina
Zdroj:	Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Dec 15; Vol. 11, pp. 752899. Date of Electronic Publication: 2021 Dec 15 (Print Publication: 2021).
DOI:	10.3389/fcimb.2021.752899
Abstrakt:	The continued proliferation of superbugs in hospitals and the coronavirus disease 2019 (COVID-19) has created an acute worldwide demand for sustained broadband pathogen suppression in households, hospitals, and public spaces. In response, we have created a highly active, self-sterilizing copper configuration capable of inactivating a wide range of bacteria and viruses in 30-60 seconds. The highly active material destroys pathogens faster than any conventional copper configuration and acts as quickly as alcohol wipes and hand sanitizers. Unlike the latter, our copper material does not release volatile compounds or leave harmful chemical residues and maintains its antimicrobial efficacy over sustained use; it is shelf stable for years. We have performed rigorous testing in accordance with guidelines from U.S. regulatory agencies and believe that the material could offer broad spectrum, non-selective defense against most microbes via integration into masks, protective equipment, and various forms of surface coatings. Competing Interests: Authors AAZ, MI, RLB, RR, AV, KKN, NTN, HTZ, NA, and RMS are employed by Kuprion®, Inc. Authors MI and HK are employed by Integrated Pharma Services. This study was funded by Kuprion®, Inc. All authors declare no other competing interests. (Copyright © 2021 Zinn, Izadjoo, Kim, Brody, Roth, Vega, Nguyen, Ngo, Zinn, Antonopoulos and Stoltenberg.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu